Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Molecules ; 27(19)2022 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-36234962

RESUMO

Cancer is a global public health problem that is related to different environmental and lifestyle factors. Although the combination of screening, prevention, and treatment of cancer has resulted in increased patient survival, conventional treatments sometimes have therapeutic limitations such as resistance to drugs or severe side effects. Oriental culture includes herbal medicine as a complementary therapy in combination with chemotherapy or radiotherapy. This study aimed to identify the bioactive ingredients in Kalanchoe pinnata, a succulent herb with ethnomedical applications for several diseases, including cancer, and reveal its anticancer mechanisms through a molecular approach. The herb contains gallic acid, caffeic acid, coumaric acid, quercetin, quercitrin, isorhamnetin, kaempferol, bersaldegenin, bryophyllin a, bryophyllin c, bryophynol, bryophyllol and bryophollone, stigmasterol, campesterol, and other elements. Its phytochemicals participate in the regulation of proliferation, apoptosis, cell migration, angiogenesis, metastasis, oxidative stress, and autophagy. They have the potential to act as epigenetic drugs by reverting the acquired epigenetic changes associated with tumor resistance to therapy-such as the promoter methylation of suppressor genes, inhibition of DNMT1 and DNMT3b activity, and HDAC regulation-through methylation, thereby regulating the expression of genes involved in the PI3K/Akt/mTOR, Nrf2/Keap1, MEK/ERK, and Wnt/ß-catenin pathways. All of the data support the use of K. pinnata as an adjuvant in cancer treatment.


Assuntos
Kalanchoe , Ácidos Cumáricos/análise , Epigênese Genética , Ácido Gálico/análise , Humanos , Quempferóis/análise , Kalanchoe/química , Kalanchoe/genética , Proteína 1 Associada a ECH Semelhante a Kelch , Quinases de Proteína Quinase Ativadas por Mitógeno , Fator 2 Relacionado a NF-E2 , Fosfatidilinositol 3-Quinases , Folhas de Planta/química , Proteínas Proto-Oncogênicas c-akt , Quercetina/farmacologia , Estigmasterol/análise , Serina-Treonina Quinases TOR , beta Catenina
2.
J Immunol Res ; 2017: 3940743, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28695135

RESUMO

Previously transgenic Kalanchoe pinnata plants producing an antimicrobial peptide cecropin P1 (CecP1) have been reported. Now we report biological testing K. pinnata extracts containing CecP1 as a candidate drug for treatment of wounds infected with Candida albicans. The drug constitutes the whole juice from K. pinnata leaves (not ethanol extract) sterilized with nanofiltration. A microbicide activity of CecP1 against an animal fungal pathogen in vivo was demonstrated for the first time. However, a favorable therapeutic effect of the transgenic K. pinnata extract was attributed to a synergism between the fungicide activity of CecP1 and wound healing (antiscar), revascularizing, and immunomodulating effect of natural biologically active components of K. pinnata. A commercial fungicide preparation clotrimazole eliminated C. albicans cells within infected wounds in rats with efficiency comparable to CecP1-enriched K. pinnata extract. But in contrast to K. pinnata extract, clotrimazole did not exhibit neither wound healing activity nor remodeling of the scar matrix. Taken together, our results allow assumption that CecP1-enriched K. pinnata extracts should be considered as a candidate drug for treatment of dermatomycoses, wounds infected with fungi, and bedsores.


Assuntos
Candidíase/tratamento farmacológico , Imunomodulação , Kalanchoe/química , Peptídeos/uso terapêutico , Extratos Vegetais/uso terapêutico , Cicatrização/efeitos dos fármacos , Infecção dos Ferimentos/tratamento farmacológico , Animais , Antifúngicos/administração & dosagem , Antifúngicos/química , Antifúngicos/isolamento & purificação , Antifúngicos/uso terapêutico , Candida albicans/efeitos dos fármacos , Candidíase/microbiologia , Clotrimazol/uso terapêutico , Dermatomicoses/tratamento farmacológico , Sinergismo Farmacológico , Kalanchoe/genética , Peptídeos/administração & dosagem , Peptídeos/metabolismo , Fitoterapia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Folhas de Planta/química , Ratos
3.
J Immunol Res ; 2017: 4645701, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28326334

RESUMO

Procedure of manufacturing K. pinnata water extracts containing cecropin P1 (CecP1) from the formerly described transgenic plants is established. It included incubation of leaves at +4°C for 7 days, mechanical homogenization of leaves using water as extraction solvent, and heating at +70°C for inactivating plant enzymes. Yield of CecP1 (after heating and sterilizing filtration) was 0.3% of total protein in the extract. The water extract of K. pinnata + CecP1 exhibits favorable effect on healing of wounds infected with S. aureus (equal to Cefazolin) and with a combination of S. aureus with P. aeruginosa (better than Cefazolin). Wild-type K. pinnata extract exhibited evident microbicide activity against S. aureus with P. aeruginosa but it was substantially strengthened in K. pinnata + CecP1 extract. K. pinnata extracts (both wild-type and transgenic) did not exhibit general toxicity and accelerated wound recovery. Due to immunomodulating activity, wild-type K. pinnata extract accelerated granulation of the wound bed and marginal epithelialization even better than K. pinnata + CecP1 extract. Immunomodulating and microbicide activity of K. pinnata synergizes with microbicide activity of CecP1 accelerating elimination of bacteria.


Assuntos
Anti-Infecciosos/uso terapêutico , Kalanchoe/genética , Peptídeos/uso terapêutico , Extratos Vegetais/uso terapêutico , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/fisiologia , Proteínas Recombinantes/uso terapêutico , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/fisiologia , Infecção dos Ferimentos/tratamento farmacológico , Animais , Cefazolina/uso terapêutico , Humanos , Imunomodulação , Masculino , Peptídeos/genética , Plantas Geneticamente Modificadas , Ratos , Ratos Wistar , Proteínas Recombinantes/genética , Suínos , Cicatrização/efeitos dos fármacos
4.
Plant Cell Rep ; 29(1): 61-77, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19921199

RESUMO

Engineered male sterility in ornamental plants has many applications such as facilitate hybrid seed production, eliminate pollen allergens, reduce the need for deadheading to extend the flowering period, redirect resources from seeds to vegetative growth, increase flower longevity and prevent gene flow between genetically modified and related native plants. We have developed a reliable and efficient Agrobacterium-mediated protocol for the genetic transformation of different Kalanchoe blossfeldiana commercial cultivars. Transformation efficiency for cv. 'Hillary' was 55.3% whereas that of cv. 'Tenorio' reached 75.8%. Selection was carried out with the nptII gene and increasing the kanamycin concentration from 25 to 100 mg l(-1) allowed to reduced escapes from 50 to 60% to virtually 0%. This method was used to produce male-sterile plants through engineered anther ablation. In our approach, we tested a male sterility chimaeric gene construct (PsEND1::barnase) to evaluate its effectiveness and effect on phenotype. No significant differences were found in the growth patterns between the transgenic lines and the wild-type plants. No viable pollen grains were observed in the ablated anthers of any of the lines carrying the PsEND1::barnase construct, indicating that the male sterility was complete. In addition, seed set was completely abolished in all the transgenic plants obtained. Our engineered male-sterile approach could be used, alone or in combination with a female-sterility system, to reduce the invasive potential of new ornamentals, which has become an important environmental problem in many countries.


Assuntos
Flores/crescimento & desenvolvimento , Engenharia Genética/métodos , Kalanchoe/genética , Infertilidade das Plantas , Flores/genética , Flores/ultraestrutura , Regulação da Expressão Gênica de Plantas , Kalanchoe/crescimento & desenvolvimento , Fenótipo , Plantas Geneticamente Modificadas/genética , Plantas Geneticamente Modificadas/crescimento & desenvolvimento , Pólen/crescimento & desenvolvimento , Regiões Promotoras Genéticas , Rhizobium , Transformação Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA